Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort

被引：0
|
作者：
Papillon-Cavanagh, Simon [1 ]
Gao, Chuan [1 ]
Han, G. Celine [1 ]
Walsh, Alice M. [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2008
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Biomarkers of Chinese advanced cancer patients based on real-world data: Actionable genomic alterations and tumor mutational burden.
    Wang, HaiTao
    Wang, Huina
    Guo, Rongyun
    Li, Mingwei
    Zhang, Yanrui
    Lou, Feng
    Cao, Shanbo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    Keyl, Julius
    Keyl, Philipp
    Montavon, Gregoire
    Hosch, Rene
    Brehmer, Alexander
    Mochmann, Liliana
    Jurmeister, Philipp
    Dernbach, Gabriel
    Kim, Moon
    Koitka, Sven
    Bauer, Sebastian
    Bechrakis, Nikolaos
    Forsting, Michael
    Fuehrer-Sakel, Dagmar
    Glas, Martin
    Gruenwald, Viktor
    Hadaschik, Boris
    Haubold, Johannes
    Herrmann, Ken
    Kasper, Stefan
    Kimmig, Rainer
    Lang, Stephan
    Rassaf, Tienush
    Roesch, Alexander
    Schadendorf, Dirk
    Siveke, Jens T.
    Stuschke, Martin
    Sure, Ulrich
    Totzeck, Matthias
    Welt, Anja
    Wiesweg, Marcel
    Baba, Hideo A.
    Nensa, Felix
    Egger, Jan
    Mueller, Klaus-Robert
    Schuler, Martin
    Klauschen, Frederick
    Kleesiek, Jens
    NATURE CANCER, 2025, 6 (02) : 307 - 322
  • [23] Systematic pan-cancer analysis of mutation–treatment interactions using large real-world clinicogenomics data
    Ruishan Liu
    Shemra Rizzo
    Sarah Waliany
    Marius Rene Garmhausen
    Navdeep Pal
    Zhi Huang
    Nayan Chaudhary
    Lisa Wang
    Chris Harbron
    Joel Neal
    Ryan Copping
    James Zou
    Nature Medicine, 2022, 28 : 1656 - 1661
  • [24] Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts
    Jelas, I
    de Bortoli, T.
    Benary, M.
    Horak, P.
    Lamping, M.
    Schaefer, R.
    Klauschen, F.
    Tinhofer-Keilholz, I
    Leyvraz, S.
    Keller, U.
    Stenzinger, A.
    Froehling, S.
    Stintzing, S.
    Kurzrock, R.
    Keilholz, U.
    Rieke, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 89 - 90
  • [25] Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data
    Liu, Ruishan
    Rizzo, Shemra
    Waliany, Sarah
    Garmhausen, Marius Rene
    Pal, Navdeep
    Huang, Zhi
    Chaudhary, Nayan
    Wang, Lisa
    Harbron, Chris
    Neal, Joel
    Copping, Ryan
    Zou, James
    NATURE MEDICINE, 2022, 28 (08) : 1656 - +
  • [26] Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort
    Olsen, Andrea
    Lebedeva, Alexandra
    Nosova, Polina
    Nikulin, Vladislav
    Sharova, Margarita
    Ignatova, Ekaterina
    Mileyko, Vladislav
    Ivanov, Maxim
    TUMORI JOURNAL, 2024, 110 (02): : 146 - 152
  • [27] Real-World Concordance Between Tumor Mutational Burden From Blood and Tissue in Lung Cancer and Other Cancers
    Park, J.
    Park, I.
    Hwang, J. Y.
    Bae, W.
    Lee, G.
    Kim, L.
    Choi, Y.
    Jung, H.
    Kim, M. J.
    Hong, S. P.
    Lee, H.
    Yu, E.
    Lee, A.
    Park, Y.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1023 - S1024
  • [28] Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiency
    Chai, Teresa S.
    Rodgers-Fouche, Linda H.
    Walls, Jenna O.
    Mattia, Anthony R.
    Chung, Daniel C.
    CANCER, 2024, 130 (22) : 3888 - 3893
  • [29] Tumour mutational burden (TMB) level and clinical outcomes in a real-world pan-tumour population
    DeClue, R.
    Kachroo, S.
    Gautam, S.
    Fisher, M. D.
    Basu, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1119 - S1119
  • [30] Pan-cancer analysis of tumor mutation burden and other key ICI biomarkers in the Indian cohort
    Vaid, Ashok Kumar
    Batra, Sandeep
    Gupta, Sachin
    Shreenivas, Aditya V.
    Rohatgi, Nitesh
    Singhal, Manish Kumar
    Kurzrock, Razelle
    Limited, Datar
    Akolkar, Dadasaheb B.
    Patil, Darshana
    Datta, Vineet
    Syed, Nelofer
    Plowman, Nick
    Limaye, Sewanti Atul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345